AstraZeneca, breast cancer and Daiichi Sankyo
Daiichi Sankyo Shares Jump After U.S. FDA Approves Breast Cancer Drug
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday after rising as much as 9.7% earlier. Over the past three years, the stock posted a daily gain of more than 8% only four times.
The U.S. Food and Drug Administration has officially banned red dye — called Red 3, or Erythrosine — from foods, dietary ...
Hosted on MSN3d
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab RatsAfter decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food ...
On January 16, the U.S. Food and Drug Administration (FDA) announced that it is revoking the authorization for use of FD&C Red No. 3 in ...
On Wednesday, the Food and Drug Administration (FDA) issued an order that will ban Red No. 3, a synthetic dye, from food, ...
The Food and Drug Administration announced Wednesday it had decided to revoke Red 3's authorization to be added to foods, over concerns about how the food coloring dye has been linked to ...
The U.S. on Wednesday banned the use of a synthetic food dye that gives some candies, cakes and certain oral medications a ...
The artificial food dye can be found in candy, beverages, chips and other packaged foods — often consumed by children.
The Food and Drug Administration (FDA) announced Wednesday it will ban Red No. 3, a common artificial food dye linked ...
Already banned in cosmetics and topical medicines since 1990, the Food and Drug Administration announced on Wednesday that ...
Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback